Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group.

PubWeight™: 6.09‹?› | Rank: Top 1%

🔗 View Article (PMID 9005276)

Published in JAMA on January 15, 1997

Authors

D Gallo1, J R George, J H Fitchen, A S Goldstein, M S Hindahl

Author Affiliations

1: Viral and Rickettsial Disease Laboratory, California State Department of Health Services, Berkeley, USA.

Articles citing this

Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health (1999) 8.91

HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health (2001) 6.16

Prevalence of HIV infection among young adults in the United States: results from the Add Health study. Am J Public Health (2006) 2.17

Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities. Am J Public Health (2006) 1.54

Geographic distribution of human immunodeficiency virus in South Africa. Am J Trop Med Hyg (2007) 1.45

Detection of antibodies to human immunodeficiency virus type 1 in oral fluids: a large-scale evaluation of immunoassay performance. Clin Diagn Lab Immunol (1998) 1.31

Health conditions among aging narcotics addicts: medical examination results. J Behav Med (2004) 1.28

Using peer recruitment and OraSure to increase HIV testing. Am J Public Health (2004) 1.22

Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia. J Urban Health (2010) 1.21

Alternative HIV testing methods among populations at high risk for HIV infection. Public Health Rep (2003) 1.17

Detection of human immunodeficiency virus antibodies in oral fluids. Clin Diagn Lab Immunol (1998) 1.06

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis (2006) 1.03

Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego. Subst Use Misuse (2010) 1.02

Intravenous drug users' HIV-risk behaviors with primary/other partners. Am J Drug Alcohol Abuse (2004) 1.00

Increasing voluntary HIV testing by offering oral tests in incarcerated populations. Am J Public Health (2001) 0.98

Longitudinal analysis of the relationship between perceived norms and sharing injection paraphernalia. AIDS Behav (2009) 0.97

Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J Psychoactive Drugs (2010) 0.96

Ethnic differences in substance use, sexual risk behaviors, and psychosocial factors in a sample of heterosexual methamphetamine users. Subst Use Misuse (2009) 0.96

Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals. Clin Diagn Lab Immunol (2003) 0.95

Correlations among inflammatory markers in plasma, saliva and oral mucosal transudate in post-menopausal women with past intimate partner violence. Brain Behav Immun (2010) 0.92

Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen. Clin Diagn Lab Immunol (2004) 0.91

Methamphetamine-using felons: psychosocial and behavioral characteristics. Am J Addict (2008) 0.90

HIV prevalence among men and women admitted to a South African public psychiatric hospital. AIDS Care (2009) 0.90

Rapid HIV testing in dental practices. Am J Public Health (2012) 0.87

Influence of host factors on immunoglobulin G concentration in oral fluid specimens. Clin Diagn Lab Immunol (2002) 0.85

Human immunodeficiency virus antibody testing by enzyme-linked fluorescent and western blot assays using serum, gingival-crevicular transudate, and urine samples. J Clin Microbiol (1999) 0.84

A simple saliva-based test for detecting antibodies to human immunodeficiency virus. Clin Diagn Lab Immunol (1999) 0.84

Interleukin-6 and soluble interleukin-6 receptor levels in posttraumatic stress disorder: associations with lifetime diagnostic status and psychological context. Biol Psychol (2014) 0.83

Factors associated with positive HIV serostatus among women who use drugs: continued evidence for expanding factors of influence. Public Health Rep (2003) 0.79

Feasibility of a Population Based Survey on HIV Prevalence in Barbados, and Population Preference for Sample Identification Method. Open AIDS J (2010) 0.79

Repeat confirmatory testing for persons with discordant whole blood and oral fluid rapid HIV test results: findings from post marketing surveillance. PLoS One (2008) 0.79

Validation of a modified commercial enzyme-linked immunoassay for detection of human immunodeficiency virus type 1 immunoglobulin G antibodies in saliva. Clin Diagn Lab Immunol (2001) 0.78

Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters. Respir Res (2015) 0.78

Gingival crevicular fluid: As a diagnostic marker in HIV positive patients. J Int Soc Prev Community Dent (2015) 0.77

Usefulness of oral mucosal transudate for HIV antibody testing. JAMA (1997) 0.76

"When you get old like this … you don't run those risks anymore": influence of age on sexual risk behaviors and condom use attitudes among methamphetamine-using heterosexual women with a history of partner violence. Womens Health Issues (2014) 0.76

Live to tell: Narratives of methamphetamine-using women taken hostage by their intimate partners in San Diego, CA. Int J Drug Policy (2015) 0.75

Usefulness of oral mucosal transudate for HIV antibody testing. JAMA (1997) 0.75

Usefulness of oral mucosal transudate for HIV antibody testing. JAMA (1997) 0.75

Usefulness of oral mucosal transudate for HIV antibody testing. JAMA (1997) 0.75

Articles by these authors

(truncated to the top 100)

Development of a chemically defined liquid medium for growth of Legionella pneumophila. J Clin Microbiol (1979) 6.10

Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA (1991) 2.94

Amino acid requirements of Legionella pneumophila. J Clin Microbiol (1980) 2.88

The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA (1996) 2.85

Brief report: infection of a laboratory worker with simian immunodeficiency virus. N Engl J Med (1994) 2.32

HIV seroprevalence surveys of childbearing women--objectives, methods, and uses of the data. Public Health Rep (1990) 2.20

Metal requirements of Legionella pneumophila. J Clin Microbiol (1981) 2.12

Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol (1992) 2.09

Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS (1997) 1.93

Methionine recycling as a target for antiprotozoal drug development. Parasitol Today (1989) 1.78

Isolation and characterization of the Legionella pneumophila outer membrane. J Bacteriol (1984) 1.74

Differential regulation by iron of regA and toxA transcript accumulation in Pseudomonas aeruginosa. J Bacteriol (1989) 1.73

Percutaneous transcatheter embolization for massive bleeding from pelvic fractures. J Trauma (1985) 1.61

Performance of a rapid, on-site human immunodeficiency virus antibody assay in a public health setting. J Clin Microbiol (1995) 1.58

Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand. AIDS (1993) 1.54

Risk factors for HIV infection among abandoned Romanian children. AIDS (1993) 1.39

Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses (1994) 1.31

Quantitative measurement of precipitating antibodies in streptococcal grouping antisera by the single radial immunodiffusion technique. Appl Microbiol (1972) 1.22

Analogs of 5-methylthioribose, a novel class of antiprotozoal agents. Antimicrob Agents Chemother (1988) 1.17

Chronic postmyelogram headache. Isotopic demonstration of dural leak and surgical cure. Arch Neurol (1971) 1.16

Metabolic and genetic studies of a family with ornithine transcarbamylase deficiency. Pediatr Res (1974) 1.14

Outer membrane proteins from Legionella pneumophila serogroups and other Legionella species. Infect Immun (1986) 1.14

Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa. AIDS (1993) 1.13

Studies of coat protein-mediated resistance to tobacco mosaic tobamovirus: correlation between assembly of mutant coat proteins and resistance. J Virol (1997) 1.12

Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc Natl Acad Sci U S A (1999) 1.11

Synthesis of plant triosephosphate isomerase in Escherichia coli. Agric Biol Chem (1990) 1.10

Procedures for the production and separation of H and M antigens in histoplasmin: chemical and serological properties of the isolated products. Mycopathologia (1977) 1.09

Lumbar arterial injury: radiologic diagnosis and management. Radiology (1987) 1.04

Selective killing of Klebsiella pneumoniae by 5-trifluoromethylthioribose. Chemotherapeutic exploitation of the enzyme 5-methylthioribose kinase. J Biol Chem (1990) 1.03

Oligomeric nature of transmembrane glycoproteins of HIV-2: procedures for their efficient dissociation and preparation of Western blots for diagnosis. AIDS (1991) 1.01

Molecular cloning and characterization of S-adenosyl-L-methionine:scoulerine-9-O-methyltransferase from cultured cells of Coptis japonica. Plant Cell Physiol (1995) 1.00

Rash and eosinophilia in a 23-year-old man. West J Med (1982) 1.00

Human immunodeficiency virus type 2 infection in the United States. Epidemiology, diagnosis, and public health implications. JAMA (1992) 0.99

The antigenic characteristics of hematopoietic stem cells. N Engl J Med (1981) 0.98

Epithelial stem cells of the prostate and their role in cancer progression. Cold Spring Harb Symp Quant Biol (2008) 0.98

Testing for antibodies to human immunodeficiency virus type 2 in the United States. MMWR Recomm Rep (1992) 0.97

Surveillance for human immunodeficiency virus type 1 group O infections in the United States. Transfusion (1996) 0.95

The diagnostic superiority of computerized tomography. J Trauma (1985) 0.94

Aplastic anemia: biology and treatment. Ann Intern Med (1981) 0.93

Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors. Cancer Res (1986) 0.93

Outer membrane protein NmpC of Escherichia coli: pore-forming properties in black lipid bilayers. J Bacteriol (1984) 0.92

Oral fluid as a specimen for detection and confirmation of antibodies to human immunodeficiency virus type 1. Clin Diagn Lab Immunol (1995) 0.91

Studies of coat protein-mediated resistance to TMV. I. The PM2 assembly defective mutant confers resistance to TMV. Virology (1995) 0.91

Synergistic activity of 5-trifluoromethylthioribose and inhibitors of methionine synthesis against Klebsiella pneumoniae. Antimicrob Agents Chemother (1991) 0.90

Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine. J Med Chem (1992) 0.89

Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper. AIDS (1993) 0.89

Future applications of oral fluid specimen technology. Am J Med (1997) 0.89

Monocytes stimulate fibroblastoid bone marrow stromal cells to produce multilineage hematopoietic growth factors. Blood (1986) 0.89

Simian immunodeficiency virus needlestick accident in a laboratory worker. Lancet (1992) 0.89

Posterior interosseous nervepalsy in the absence of trauma. Arch Neurol (1969) 0.89

Human immunodeficiency virus (HIV) antigens: structure and serology of multivalent human mucin MUC1-HIV V3 chimeric proteins. Proc Natl Acad Sci U S A (1995) 0.87

Expression of Ia-like and HLA-A,B antigens on human multipotential hematopoietic progenitor cells. Blood (1982) 0.87

The management of arterial injuries caused by penetration of zone III of the neck. J Trauma (1985) 0.87

Central venous blood oxygen saturation: an early, accurate measurement of volume during hemorrhage. J Trauma (1988) 0.86

Factors influencing HIV-1 banding patterns in miniaturized western blot testing of dried blood spot specimens. J Immunol Methods (1992) 0.86

Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type 2. Clin Diagn Lab Immunol (1997) 0.86

Human myeloid progenitor cells expressing HLA antigens. Blood (1979) 0.85

Intussusception following abdominal trauma. J Trauma (1987) 0.85

Cimetidine and granulopoiesis: bone marrow culture studies in normal man and patients with cimetidine-associated neutropenia. Br J Haematol (1980) 0.85

Effect of 5'-methylthioadenosine (a naturally occurring nucleoside) on murine hematopoiesis. Exp Hematol (1984) 0.85

Benign clear cell tumor of the lung. Arch Pathol Lab Med (1979) 0.84

Methylthioadenosine phosphorylase deficiency in acute leukemia: pathologic, cytogenetic, and clinical features. Blood (1988) 0.84

Monoclonal antibodies to HLA-A,B, and Ia-like antigens inhibit colony formation by human myeloid progenitor cells. J Immunol (1980) 0.84

The development and evaluation of a probe hybridization method for subtyping HIV type 1 infection in Uganda. AIDS Res Hum Retroviruses (1998) 0.84

A simple method for freezing lymphocytes in microtest plates. Am J Clin Pathol (1981) 0.83

Purine metabolism as a target for leukemia chemotherapy. Blood Rev (1989) 0.82

HIV-1 serologic test results for one million newborn dried-blood specimens: assay performance and implications for screening. J Acquir Immune Defic Syndr (1992) 0.82

Quantitative measurement of precipitating antibodies and standardization of Streptococcus group B antisera by the reverse radial immunodiffusion technique. Bull World Health Organ (1974) 0.81

Amyloidosis and granulomatous ileocolitis. Regression after surgical removal of the involved bowel. N Engl J Med (1975) 0.81

Arylsulfatase from Pseudomonas sp. strain C12B: purification to homogeneity, immunological analysis, and physical properties. J Bacteriol (1981) 0.81

Recent developments in understanding the pathogenesis of aplastic anemia. Am J Hematol (1978) 0.81

Localization of arylsulfatase in Pseudomonas C12B. Appl Environ Microbiol (1977) 0.81

Use of plant viruses for delivery of vaccine epitopes. Ann N Y Acad Sci (1996) 0.80

Misidentification of HIV-2 proteins by western blots. Lancet (1991) 0.80

Evaluation of testing algorithms following the use of combination HIV-1/HIV-2 EIA for screening purposes. AIDS Res Hum Retroviruses (1993) 0.80

Importance of confirmatory tests after strongly positive HTLV-III screening tests. N Engl J Med (1986) 0.80

Arterial trauma: diagnostic and therapeutic angiography. Radiology (1986) 0.80

Gentamicin therapy of Paracolobactrum epidural abscess and meningitis. Am J Med Sci (1969) 0.79

Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation. J Clin Invest (1985) 0.79

A highly heterogeneous HIV-1 epidemic in the Central African Republic. Emerg Infect Dis (1996) 0.79

"Stromal" and hemopoietic stem cell abnormalities in long-term cultures of marrow from busulfan-treated mice. Exp Hematol (1982) 0.79

Serum inhibitors of myelopoiesis. Br J Haematol (1980) 0.79

Inhibition of growth but not differentiation of normal and leukemic myeloid cells by methylthioadenosine. Cancer Res (1987) 0.79

Removal of Paracoccus denitrificans outer membrane material by sodium chloride. Arch Microbiol (1981) 0.78

Expression of Ia-like antigens in human erythroid progenitor cells as determined by monoclonal antibodies and heteroantiserum to Ia-like antigens. Clin Immunol Immunopathol (1981) 0.78

Expression of the H-2 antigenic complex on murine haematopoietic stem cells. Scand J Immunol (1982) 0.78

Injuries missed at operation: nemesis of the trauma surgeon. J Trauma (1988) 0.78

An in vitro model of hematopoietic injury in chronic hypoplastic anemia. Cell Tissue Kinet (1981) 0.78

Serum inhibitors of in vitro hematopoiesis and graft outcome in bone marrow transplantation for aplastic anemia. Transplantation (1980) 0.78

The effect of granulopoietic stress in mice with "latent" bone marrow failure. Exp Hematol (1980) 0.78

An antigen expressed by cells of the myelo-monocytic lineage. Am J Hematol (1981) 0.78

Lack of association between anti-V3 loop antibody and perinatal HIV-1 transmission in Kinshasa, Zaire, despite use of assays based on local HIV-1 strains. J Acquir Immune Defic Syndr (1994) 0.77

Tyramine-mediated enhancement of arylsulphatase purified from Pseudomonas C12B [proceedings]. Biochem Soc Trans (1979) 0.77

Routine versus selective exploration of penetrating neck injuries: a randomized prospective study. J Trauma (1984) 0.77

An antithymocyte serum noncytotoxic to myeloid progenitor cells: candidate serum for prevention of graft-versus-host disease in bone marrow transplantation. Clin Immunol Immunopathol (1980) 0.77

Percutaneous transcatheter embolization for arterial trauma. J Vasc Surg (1985) 0.77

Presence of HTLV-I and HTLV-II infection in Honduras. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.76

The cost-effectiveness of voluntary counseling and testing of hospital patients for HIV. JAMA (1995) 0.75

Stimulation of bacterial arylsulfatase activity by arylamines: evidence for substrate activation. J Bacteriol (1981) 0.75

HIV-1 variants: yet another challenge to public health. Lancet (1994) 0.75